In a medical first, a human has been treated with stem cells from human embryos in a study authorized by the Food and Drug Administration.
Geron Corp. issued a press release on Monday to the effect that it had injected millions of stem cells from human embryos -- derived from a process that kills a tiny human being -- into the site of damage of a spinal injury patient (see related story). Geron describes the clinical trial as "a new chapter in medical therapeutics -- one that reaches beyond pills to a new level of healing" achieved by injecting cells manufactured from human embryonic stem cells.
But Dr. David Prentice of Family Research Council calls it "science by press release -- if it's science at all."
"Geron really ought to be ashamed. This is irresponsible," he states. "All they're doing is boosting their stock price. They're not helping science, [and] they're certainly not helping patients. It'll be years before they have any hard evidence as to whether this has helped the patient, or even whether it's safe." Read more